Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity

v3.20.1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2017 $ 2 $ 4 $ 32,010 $ (28,382) $ 3,634
Beginning balance, shares at Dec. 31, 2017 2,483,142 304 3,935,865      
Stock-based compensation related to options granted to employees 889 889
Exercise of warrants for common stock 91 91
Exercise of warrants for common stock, shares 67,670      
Exercise of stock options for common stock 3 $ 3
Exercise of stock options for common stock, shares 48,017    
Exchange of common Stock into Preferred D
Exchange of common Stock into Preferred D, shares 250,000 (250,000)      
Issuance of common stock as compensation for services, shares            
Net loss (4,154) (4,154)
Ending balance at Dec. 31, 2018 $ 2 $ 4 32,993 (32,536) $ 463
Ending balance, shares at Dec. 31, 2018 2,733,142 304 3,801,552      
Exercise of stock options for common stock, shares            
Issuance of common stock as compensation for services 1,042 $ 1,042
Issuance of common stock as compensation for services, shares 275,000      
Stock-based compensation 713 713
Sale of common stock $ 1 629 630
Sale of common stock, shares 315,000      
Exercise of options 66 66
Exercise of options, shares 87,212      
Issuance of Series E Preferred Stock $ 2 3,618 3,620
Issuance of Series E Preferred Stock, shares 1,810,000      
Reclassification of warrants 196 196
Warrant modification expense 412 412
Exchange of common Stock into Preferred Stock
Exchange of common Stock into Preferred Stock, shares 260,000 15,000 (275,000)      
Net loss (5,794) (5,794)
Ending balance at Dec. 31, 2019 $ 2 $ 2 $ 5 $ 39,669 $ (38,330) $ 1,348
Ending balance, shares at Dec. 31, 2019 2,993,142 304 1,825,000 4,203,764